Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs.
Ratings
4 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Mr. Scott A. Smith$13.4B
Market Cap • 19/04/20242014
(há 10 anos)
1986
(38 years ago)
NASDAQ
ListagemS&P500 Participant
Index Composite • 2024
Canonsburg
Sede • Pennsylvania37.000
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
VTRSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.